ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...

This is because it is difficult to predict just how much medicine gets in and where it goes in the lung. Similar challenges ...

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...

“Sometimes we use inhalers or steroids, especially in patients who have a history of asthma or chronic lung disease.” Most people with pneumonia can manage their symptoms at home by drinking ...